Enzyme-preview

Enzyme-2

Enzyme

Private

ZugCrypto & Web3https://enzyme.finance/

Last Round

Series A

Sep 27, 2021

Total Funding Raised

$8.4M

Company Overview

Enzyme is a financial software company that provides a decentralized asset management protocol built on Ethereum.

Sector

Crypto & Web3

Verticals

DeFi, Investment Platforms, Wealth Management, Tokenization, Blockchain Infrastructure

Business Model

B2B

Customer Profile

Payment Processing Fee, Services & Consulting

AI Layer

Non-AI

Keywords

on-chain asset managementdecentralized asset managementon-chain fundsDeFi portfolio managementcrypto fund platformtokenized fundsDAO treasury managementVault as a ServiceVaaSsmart contract fundsnon-custodial asset managementDeFi aggregatoryield farming toolswallet tokenizationMelon Protocol

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enzyme Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Enzyme Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Sep 27, 2021
Initial Coin Offering	Feb 15, 2017

View all Funding Rounds

Enzyme Investors

Notable investors and investment history

Investor	Rounds
CoinShares	Series A
Bitcoin Suisse	Initial Coin Offering
Acrew Capital	Series A
Collaborative Fund	Series A
Placeholder Venture Capital	Series A
Blockchange Ventures	Series A
Jump Capital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 25, 2025
Grew 25% QoQ, from 12 to 15 employees.
Dec 13, 2024
Grew 36% QoQ from 11 to 15 employees.

View all signals

Enzyme Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Enzyme Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enzyme's valuation, stock price, and market status.

Firmographic Details

HeadquartersZug

Employee Range15

Year Founded2016

Last FundingSep 27, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.